Deutsch English Français

Contact

EP1228203

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1228203

EP1228203 - PEPTIDE (VIRIP) WHICH INHIBITS A CIRCULATING VIRUS IN HUMANS AND THE USE THEREOF [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 24.04.2009 Database last updated on 15.06.2024
Most recent event Tooltip	24.04.2009	No opposition filed within time limit	published on 27.05.2009 [2009/22]
Applicant(s)	For all designated states IPF Pharmaceuticals GmbH Feodor-Lynen-Str. 31 30625 Hannover / DE
	[2003/29]
Former [2002/32]	For all designated states IPF Pharmaceuticals GmbH Feodor-Lynen-Str. 31 30625 Hannover / DE
	For all designated states Kirchhoff, Frank Schlossgarten 4 91054 Erlangen / DE
Inventor(s)	01 / KIRCHHOFF, Frank Gleisselstetten 107 89092 Ulm / DE
	02 / MÜNCH, Jan Weserstrasse 6 89231 Neu-Ulm / DE
	03 / STÄNDKER, Ludger Schlegelplatz 1 30625 Hannover / DE
	04 / FORSSMANN, Wolf-Georg; Wambach 2 30625 Hannover / DE
	05 / ADERMANN, Knut; Schleidenstrasse 5 30177 Hannover / DE
	[2008/21]
Former [2002/45]	01 / KIRCHHOFF, Frank Schmiedgasse 21-3 89077 Ulm / DE
	02 / MÜNCH, Jan Alte Steige 30 89129 Langenau / DE
	03 / STÄNDKER, Ludger Dohmeyers Weg 6 30625 Hannover / DE
	04 / FORSSMANN, Wolf-Georg; IPF PharmaCeuticals GmbH;, Feodor-Lynen-Str. 31 30625 Hannover / DE
	05 / ADERMANN, Knut; IPF PharmaCeuticals GmbH;, Feodor-Lynen-Str. 31 30625 Hannover / DE
Former [2002/39]	01 / KIRCHHOFF, Frank Schmiedgasse 21 89077 Ulm / DE
	02 / MÜNCH, Jan Alte Steige 30 89129 Langenau / DE
	03 / STÄNDKER, Ludger Dohmeyers Weg 6 30625 Hannover / DE
	04 / FORSSMANN, Wolf-Georg; IPF PharmaCeuticals GmbH;, Feodor-Lynen-Str. 31 30625 Hannover / DE
	05 / ADERMANN, Knut; IPF PharmaCeuticals GmbH;, Feodor-Lynen-Str. 31 30625 Hannover / DE
Former [2002/36]	01 / KIRCHHOFF, Frank Schmiedgasse 21 89077 Ulm / DE
	02 / MÜNCH, Jan Alte Steige 30 89129 Langenau / DE
	03 / STÄNDKER, Ludger Dohmeyers Weg 25 30625 Hannover / DE
	04 / FORSSMANN, Wolf-Georg; IPF PharmaCeuticals GmbH;, Feodor-Lynen-Str. 31 30625 Hannover / DE
	05 / ADERMANN, Knut; IPF PharmaCeuticals GmbH;, Feodor-Lynen-Str. 31 30625 Hannover / DE
Former [2002/32]	01 / KIRCHHOFF, Frank Schlossgarten 4 91054 Erlangen / DE
	02 / MÜNCH, Jan Schlossgarten 4 91054 Erlangen / DE
	03 / STÄNDKER, Ludger Dohmeyers Weg 25 30625 Hannover / DE
	04 / FORSSMANN, Wolf-Georg; IPF PharmaCeuticals GmbH;, Feodor-Lynen-Str. 31 30625 Hannover / DE
	05 / ADERMANN, Knut; IPF PharmaCeuticals GmbH;, Feodor-Lynen-Str. 31 30625 Hannover / DE
Representative(s)	dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln / DE
	[N/P]
Former [2002/32]	Meyers, Hans-Wilhelm, Dr.Dipl.-Chem., et al Patentanwälte von Kreisler-Selting-Werner Postfach 10 22 41 50462 Köln / DE
Application number, filing date	00987221.9	08.11.2000
	[2002/32]
	WO2000EP11020
Priority number, date	DE1999153732	08.11.1999 Original published format: DE 19953732
	DE2000123665	16.05.2000 Original published format: DE 10023665
	[2002/32]
Filing language	DE
Procedural language	DE
Publication	Type:	A2 Application without search report
	No.:	WO0134640
	Date:	17.05.2001
	Language:	DE
	[2001/20]
	Type:	A2 Application without search report
	No.:	EP1228203
	Date:	07.08.2002
	Language:	DE
	The application published by WIPO in one of the EPO official languages on 17.05.2001 takes the place of the publication of the European patent application.
	[2002/32]
	Type:	B1 Patent specification
	No.:	EP1228203
	Date:	18.06.2008
	Language:	DE
	[2008/25]
Search report(s)	International search report - published on:	EP	01.11.2001
Classification	IPC:	C12N15/11, C12N15/12, C07K7/08, C07K14/435, C12N15/62, C12N15/63, C07K16/40, A61K38/10, A61P31/18	[2002/32]
	CPC:	C07K7/08 (EP,US); A61P17/02 (EP); A61P19/00 (EP); A61P25/00 (EP); A61P29/00 (EP); A61P31/04 (EP); (+) A61P31/10 (EP); A61P31/12 (EP); A61P31/16 (EP); A61P31/18 (EP); A61P31/22 (EP); A61P35/00 (EP); A61P37/00 (EP); A61P43/00 (EP); A61P7/00 (EP); A61P9/14 (EP); A61K38/00 (EP,US) (-)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2002/32]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	HUMANES ZIRKULIERENDES VIRUS INHIBIERENDES PEPTID (VIRIP) UND SEINE VERWENDUNG	[2002/32]
	English:	PEPTIDE (VIRIP) WHICH INHIBITS A CIRCULATING VIRUS IN HUMANS AND THE USE THEREOF	[2002/32]
	French:	PEPTIDE INHIBITEUR DE VIRUS CIRCULANT CHEZ L'HOMME (VIRIP) ET SON UTILISATION	[2002/32]
Entry into regional phase	19.04.2002	National basic fee paid
	19.04.2002	Designation fee(s) paid
	19.04.2002	Examination fee paid
Examination procedure	08.06.2001	Request for preliminary examination filed International Preliminary Examining Authority: EP
	19.04.2002	Amendment by applicant (claims and/or description)
	19.04.2002	Examination requested [2002/32]
	01.09.2005	Despatch of a communication from the examining division (Time limit: M04)
	28.12.2005	Reply to a communication from the examining division
	30.01.2006	Despatch of a communication from the examining division (Time limit: M06)
	22.07.2006	Reply to a communication from the examining division
	04.08.2006	Despatch of a communication from the examining division (Time limit: M06)
	24.01.2007	Reply to a communication from the examining division
	13.02.2007	Despatch of a communication from the examining division (Time limit: M04)
	06.06.2007	Reply to a communication from the examining division
	16.08.2007	Communication of intention to grant the patent
	31.01.2008	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
	10.04.2008	Fee for grant paid
	10.04.2008	Fee for publishing/printing paid
Divisional application(s)	EP08156639.0 / EP1959013
Opposition(s)	19.03.2009	No opposition filed within time limit [2009/22]
Request for further processing for:	The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
	10.04.2008	Request for further processing filed
	10.04.2008	Full payment received (date of receipt of payment) Request granted
	29.04.2008	Decision despatched
Fees paid	Renewal fee
	28.11.2002	Renewal fee patent year 03
	26.11.2003	Renewal fee patent year 04
	13.11.2004	Renewal fee patent year 05
	28.11.2005	Renewal fee patent year 06
	28.11.2006	Renewal fee patent year 07
	28.11.2007	Renewal fee patent year 08
	31.03.2008	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[X]WO8402918 (TRANSGENE SA [FR]) [X] 3-8 * page 36, line 6 *;
		[A]US5420110 (MILLER EDWARD J [US]) [A] 1-8,10-19 * column 2, lines 20,21 *;
		[XA]WO9746100 (UNIV CASE WESTERN RESERVE [US]) [X] 1-8 * SEQ ID NO:31 * [A] 10-19;
		[X] - "H. sapiens alpha-AT1 partial cDNA clone", GENBANK, (19961213), XP002164956 [X] 3 * the whole document *
		[T] - SHAPIRO LELAND ET AL, "Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.", FASEB JOURNAL, (200101), vol. 15, no. 1, ISSN 0892-6638, pages 115 - 122, XP002164955 [T] 1-8,10-19 * the whole document * DOI: http://dx.doi.org/10.1096/fj.00-0311com

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p